Advances in Oncology Extend Lives, but Lead to New Safety Considerations for Sponsors and InvestigatorsDownload PDF
From cardiovascular adverse events to complex dosing regimens, oncology trials present unique safety-related considerations. Left unaddressed, they could undermine a trial or put patient safety at risk. In this paper, we discuss some of those issues and how sponsors can best address them.
Speak With Our Experts